The Ghana Allocation
Ghana has been allocated US$193,980,639 from the Global Fund for HIV, Tuberculosis, Malaria and building resilient and sustainable systems for health for 2018-2020. This amount represents a significant drop from the US$247,900,325 that were signed in 2015. In spite of this substantial reduction, Ghana remains one of the 20 countries worldwide with the highest allocations.
The indicative program split that is subject to CCM decision making is given as follows:
- HIV: US$66,436,395
- TB: US$16,012,823
- Malaria: US$111,531,421
If the Ghana CCM decides to adopt this proposed budget split, the situation per disease component is as follows (based on actual 2015-2017 budgets, not allocations):
Beyond the above allocation, Ghana is eligible to have access to a stream of additional matching funding, also called catalytic investment funding. This funding stream aims to incentivize the programming and use of country allocations towards the scale up of evidence informed HIV programs for key and vulnerable populations (3.6m USD) and removing human rights barriers in access to HIV programs (2.3m USD).
Ghana is further expected to submit a prioritized and costed above allocation request listing those interventions that shall be implemented once additional funds become available.
The CCM developped a funding request, i.e. a proposal, through an inclusive and evidence informed country dialogue, national disease strategies and health plans. The CCM’s request is also guided by the Global Fund’s new strategy for the period 2017-2022 on investing to end AIDS, TB and Malaria with a focus on:
- Maximizing impact against HIV, TB and Malaria
- Building resilient and sustainable systems for health
- Promoting and protecting human rights and gender equality, and;
- Mobilizing increased resources, both domestically and internationally
Ghana submitted the funding requests on 23rd May 2017. After a period of grant negotiations, all grants were signed in January/February 2018.